[Skip to Navigation]
Comment & Response
February 6, 2019

Mohs Appropriate Use Criteria for Superficial Basal Cell Carcinoma

Author Affiliations
  • 1The Skin Cancer Center, Cincinnati, Ohio
  • 2Good Samaritan Hospital, Trihealth, Cincinnati, Ohio
JAMA Dermatol. 2019;155(3):394-395. doi:10.1001/jamadermatol.2018.3719

To the Editor We read with interest the Viewpoint by Steinman and colleagues1 suggesting a reevaluation of appropriate use criteria for Mohs micrographic surgery (MMS) with respect to primary superficial basal cell carcinoma (sBCC). We must note that MMS is only 1 means of margin control of skin cancers, and perhaps the Viewpoint title would more accurately read “Reevaluation of Excisional Surgery for Primary Basal Cell Carcinoma.”

Add or change institution